8ITT image
Deposition Date 2023-03-22
Release Date 2024-01-31
Last Version Date 2024-11-13
Entry Detail
PDB ID:
8ITT
Title:
Crystal structure of lysophosphatidylcholine in complex with human serum albumin and myristate
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.03 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Albumin
Gene (Uniprot):ALB
Chain IDs:A, B
Chain Length:580
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Crystal structures of human serum albumin in complex with lysophosphatidylcholine.
Biophys.J. 122 4135 4143 (2023)
PMID: 37731243 DOI: 10.1016/j.bpj.2023.09.007

Abstact

Lysophospholipids (lysoPLs) are crucial metabolites involved in various physiological and pathological cellular processes. Understanding their binding interactions, particularly with human serum albumin (HSA), is essential due to their role in regulating lysoPLs-induced cytotoxicity. However, the precise mechanism of lysoPLs binding to HSA remains elusive. In this study, we employed fluorescence quenching and optical interferometry assays to demonstrate direct binding between lysophosphatidylcholine (LPC) and HSA (KD = 25 μM). Furthermore, we determined crystal structures of HSA in complex with LPC, both in the absence and the presence of the endogenous fatty acid myristate (14:0). The crystal structure of binary HSA:LPC revealed that six LPC molecules are bound to HSA at the primary fatty acid binding sites. Interestingly, the ternary HSA:Myr:LPC structure demonstrated the continued binding of three LPC molecules to HSA at binding sites 1, 3, and 5 in the presence of myristate. These findings support HSA's role as a carrier protein for lysoPLs in blood plasma and provide valuable insights into the structural basis of their binding mechanisms.

Legend

Protein

Chemical

Disease

Primary Citation of related structures